(Q51779657)
Statements
1 reference
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127. (English)
1 reference
Cecilia M Fenoglio-Preiser
1 reference
Tomislav Dragovich
1 reference
Sheryl McCoy
1 reference
Jiang Wang
1 reference
Jacqueline K Benedetti
1 reference
Amanda F Baker
1 reference
Christopher B Hackett
1 reference
Susan G Urba
1 reference
Ken S Zaner
1 reference
Charles D Blanke
1 reference
James L Abbruzzese
1 reference
1 October 2006
1 reference
24
1 reference
30
1 reference
4922-4927
1 reference
Identifiers
1 reference